FRM
GH icon

Fox Run Management’s Guardant Health GH Stock Holding History

Fox Run Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
+14,194
New +$1.54M 0.35% 15
2025
Q4 		– Sell
-9,998
Closed -$625K – 1031
2025
Q3 		$625K Buy
+9,998
New +$544K 0.1% 396
2025
Q1 		– Sell
-12,084
Closed -$369K – 1018
2024
Q4 		$369K Buy
+12,084
New +$340K 0.07% 545
2024
Q2 		– Sell
-25,652
Closed -$529K – 874
2024
Q1 		$529K Buy
25,652
+7,561
+42% +$162K 0.11% 351
2023
Q4 		$489K Buy
+18,091
New +$475K 0.12% 305
2023
Q3 		– Sell
-23,761
Closed -$851K – 801
2023
Q2 		$851K Sell
23,761
-21,745
-48% -$624K 0.24% 122
2023
Q1 		$1.07M Buy
45,506
+26,289
+137% +$751K 0.35% 49
2022
Q4 		$523K Buy
19,217
+7,457
+63% +$341K 0.21% 162
2022
Q3 		$633K Buy
11,760
+5,395
+85% +$277K 0.25% 104
2022
Q2 		$257K Buy
6,365
+2,660
+72% +$132K 0.13% 348
2022
Q1 		$245K Buy
+3,705
New +$254K 0.14% 347
2020
Q3 		– Sell
-4,272
Closed -$347K – 233
2020
Q2 		$347K Buy
4,272
+600
+16% +$48.3K 0.46% 76
2020
Q1 		$256K Sell
3,672
-379
-9% -$29.1K 0.61% 43
2019
Q4 		$317K Buy
+4,051
New +$292K 0.26% 172

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Fox Run Management's GH Position: Q2 2026 in Review

Fox Run Management opened a new position in Guardant Health (GH) in Q2 2026: 14,194 shares worth $2.13M. The stake represents 0.35% of the portfolio and ranks #15 among its holdings. This is a return to the name: Fox Run Management previously reported a position in GH as recently as Q3 2025.

Fox Run Management first reported a position in GH in Q4 2019 and has held it in 14 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Fox Run Management held 14,194 shares of Guardant Health worth $2.13M as of Q2 2026.
  • Guardant Health was a new Fox Run Management position in Q2 2026.
  • Guardant Health made up 0.35% of Fox Run Management's portfolio in Q2 2026, its #15 holding.
  • Fox Run Management first reported a position in Guardant Health in Q4 2019 and has held it in 14 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.